{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:19:36Z","timestamp":1789827576701,"version":"4.0.1"},"reference-count":86,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteonecrosis (ON) represents one of the most common and debilitating sequelae of antileukemic treatment in children and adolescents with acute lymphoblastic leukemia (ALL). Systematic screening strategies can focus on early detection and intervention to prevent ON from progressing to stages associated with pain and functional impairment. These strategies hold promise for reducing ON-associated morbidity without the risk of impairing leukemia control. Herein, we critically reviewed clinical data on pharmacological, nonpharmacological\/nonsurgical, and surgical (including cellular) treatment options for ON, which are covered in the literature and\/or are conceivable based on the supposed underlying ON pathophysiology. Prevention of ON progression is of paramount importance, and attempts seem to be more effective in early (precollapse) disease status than in late-stage (collapse) ON. Based on the results of ongoing prospective magnetic resonance imaging screening studies, which will hopefully identify those patients with a high risk of ON progression and debilitating sequelae, prospective interventional studies are urgently needed. Although there is still a lack of high-quality studies, based on currently available data, core decompression surgery combined with cellular therapies (eg, employing mesenchymal stem cells) appears most promising for preventing joint infraction in children at high risk of developing late-stage ON.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017007286","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:50:13Z","timestamp":1497401413000},"page":"981-994","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":29,"title":["Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge"],"prefix":"10.1182","volume":"1","author":[{"given":"Michaela","family":"Kuhlen","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kunstreich","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathinka","family":"Krull","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Meisel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology, and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"issue":"27","key":"2019111616231276000_B1","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111616231276000_B2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3324\/haematol.2012.081265","article-title":"Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood","volume":"98","author":"Girard","year":"2013","journal-title":"Haematologica"},{"issue":"9","key":"2019111616231276000_B3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1470-2045(12)70274-7","article-title":"Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial","volume":"13","author":"Mattano","year":"2012","journal-title":"Lancet Oncol"},{"issue":"9","key":"2019111616231276000_B4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(12)70315-7","article-title":"Steroids and risk of osteonecrosis in ALL: take a break","volume":"13","author":"van den Heuvel-Eibrink","year":"2012","journal-title":"Lancet Oncol"},{"issue":"31","key":"2019111616231276000_B5","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2011.37.3217","article-title":"Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia","volume":"29","author":"te Winkel","year":"2011","journal-title":"J Clin Oncol"},{"key":"2019111616231276000_B6","article-title":"Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia: first findings of the OPAL trial [published online ahead of print 31 January 2017]","author":"Krull","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2019111616231276000_B7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<11::AID-MPO4>3.0.CO;2-F","article-title":"Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study","volume":"32","author":"Ojala","year":"1999","journal-title":"Med Pediatr Oncol"},{"issue":"10","key":"2019111616231276000_B8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(09)70228-1","article-title":"Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004)","volume":"10","author":"Veerman","year":"2009","journal-title":"Lancet Oncol"},{"issue":"11","key":"2019111616231276000_B9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1651-2227.1998.tb00923.x","article-title":"Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996","volume":"87","author":"Gustafsson","year":"1998","journal-title":"Acta Paediatr"},{"issue":"12","key":"2019111616231276000_B10","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.leu.2401961","article-title":"Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation","volume":"14","author":"Gustafsson","year":"2000","journal-title":"Leukemia"},{"issue":"2","key":"2019111616231276000_B11","first-page":"150","article-title":"Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X","volume":"6","author":"Pui","year":"1992","journal-title":"Leukemia"},{"issue":"2","key":"2019111616231276000_B12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","article-title":"Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia","volume":"92","author":"Pui","year":"1998","journal-title":"Blood"},{"issue":"Suppl 1","key":"2019111616231276000_B13","first-page":"S124","article-title":"Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia","volume":"83","author":"Pui","year":"2004","journal-title":"Ann Hematol"},{"issue":"6","key":"2019111616231276000_B14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.leu.2402139","article-title":"Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma","volume":"15","author":"Ribeiro","year":"2001","journal-title":"Leukemia"},{"issue":"12","key":"2019111616231276000_B15","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2006.06.2539","article-title":"High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia","volume":"25","author":"Niinim\u00e4ki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111616231276000_B16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1200\/JCO.2006.07.9947","article-title":"Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma","volume":"25","author":"Karimova","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111616231276000_B17","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","article-title":"Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia","volume":"117","author":"Kawedia","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111616231276000_B18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2014.57.5480","article-title":"Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids","volume":"33","author":"Kaste","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111616231276000_B19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00256-016-2329-3","article-title":"Lower-limb MRI in the staging and re-staging of osteonecrosis in paediatric patients affected by acute lymphoblastic leukaemia after therapy","volume":"45","author":"Ippolito","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"12","key":"2019111616231276000_B20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.crad.2015.08.011","article-title":"The classification of osteonecrosis in patients with cancer: validation of a new radiological classification system","volume":"70","author":"Niinim\u00e4ki","year":"2015","journal-title":"Clin Radiol"},{"issue":"6","key":"2019111616231276000_B21","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","article-title":"Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus","volume":"17","author":"Schmiegelow","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"2019111616231276000_B22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3324\/haematol.2013.095562","article-title":"Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia","volume":"99","author":"Te Winkel","year":"2014","journal-title":"Haematologica"},{"issue":"324","key":"2019111616231276000_B23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00003086-199603000-00020","article-title":"Core decompression versus nonoperative management for osteonecrosis of the hip","author":"Mont","year":"1996","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"2019111616231276000_B24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2106\/00004623-199503000-00018","article-title":"Non-traumatic avascular necrosis of the femoral head","volume":"77","author":"Mont","year":"1995","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"2019111616231276000_B25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2613.2012.00836.x","article-title":"Weight bearing does not contribute to the development of osteonecrosis of the femoral head","volume":"93","author":"Okazaki","year":"2012","journal-title":"Int J Exp Pathol"},{"issue":"11","key":"2019111616231276000_B26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3324\/haematol.2016.147595","article-title":"Osteonecrosis in children with acute lymphoblastic leukemia","volume":"101","author":"Kunstreich","year":"2016","journal-title":"Haematologica"},{"issue":"15","key":"2019111616231276000_B27","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2015-05-643601","article-title":"Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia","volume":"126","author":"Karol","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111616231276000_B28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajpath.2013.03.004","article-title":"Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis","volume":"183","author":"Janke","year":"2013","journal-title":"Am J Pathol"},{"issue":"435","key":"2019111616231276000_B29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.blo.0000157539.67567.03","article-title":"Enoxaparin prevents progression of stages I and II osteonecrosis of the hip","author":"Glueck","year":"2005","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"2019111616231276000_B30","doi-asserted-by":"crossref","first-page":"e911","DOI":"10.3928\/01477447-20140924-59","article-title":"Medical treatment of osteonecrosis of the knee associated with thrombophilia-hypofibrinolysis","volume":"37","author":"Glueck","year":"2014","journal-title":"Orthopedics"},{"issue":"5","key":"2019111616231276000_B31","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2526","article-title":"Rationale for prostaglandin I2 in bone marrow oedema--from theory to application","volume":"10","author":"J\u00e4ger","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"2019111616231276000_B32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1302\/0301-620X.87B4.15658","article-title":"The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost","volume":"87","author":"Disch","year":"2005","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"2019111616231276000_B33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00508-005-321-3","article-title":"Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study","volume":"117","author":"Aigner","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"2019111616231276000_B34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0019-5413.45321","article-title":"Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost","volume":"43","author":"Meizer","year":"2009","journal-title":"Indian J Orthop"},{"issue":"386","key":"2019111616231276000_B35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-200105000-00022","article-title":"Statin therapy decreases the risk of osteonecrosis in patients receiving steroids","author":"Pritchett","year":"2001","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"2019111616231276000_B36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/archdischild-2015-309934","article-title":"QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?","volume":"101","author":"Amin","year":"2016","journal-title":"Arch Dis Child"},{"issue":"7","key":"2019111616231276000_B37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/pbc.22428","article-title":"Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL)","volume":"54","author":"Kotecha","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"2019111616231276000_B38","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/206132","article-title":"Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies","author":"Greggio","year":"2010"},{"issue":"9","key":"2019111616231276000_B39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/pbc.24563","article-title":"Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis","volume":"60","author":"Padhye","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2019111616231276000_B40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/pbc.24313","article-title":"Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia","volume":"60","author":"Leblicq","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2019111616231276000_B41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/JPEM.2006.19.2.161","article-title":"Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes","volume":"19","author":"Nguyen","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2019111616231276000_B42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1191\/1078155205jp145oa","article-title":"Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin\u2019s lymphoma: results of a pilot study","volume":"11","author":"Wiernikowski","year":"2005","journal-title":"J Oncol Pharm Pract"},{"issue":"19","key":"2019111616231276000_B43","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1073\/pnas.0912176107","article-title":"ACTH protects against glucocorticoid-induced osteonecrosis of bone","volume":"107","author":"Zaidi","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111616231276000_B44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.orthres.2004.08.013","article-title":"Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone","volume":"23","author":"Katsube","year":"2005","journal-title":"J Orthop Res"},{"issue":"5","key":"2019111616231276000_B45","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.3324\/haematol.2016.160507","article-title":"Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia","volume":"102","author":"Mogensen","year":"2017","journal-title":"Haematologica"},{"issue":"15","key":"2019111616231276000_B46","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.ejca.2014.06.023","article-title":"Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia","volume":"50","author":"Bhojwani","year":"2014","journal-title":"Eur J Cancer"},{"issue":"6","key":"2019111616231276000_B47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jbspin.2007.12.008","article-title":"Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits","volume":"75","author":"Pengde","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"12","key":"2019111616231276000_B48","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1359\/jbmr.060905","article-title":"RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis","volume":"21","author":"Kim","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2019111616231276000_B49","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2019111616231276000_B50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12178-009-9046-7","article-title":"RANK, RANKL and osteoprotegerin in bone biology and disease","volume":"2","author":"Wright","year":"2009","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"9","key":"2019111616231276000_B51","first-page":"10460","article-title":"Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway","volume":"8","author":"Miao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"2019111616231276000_B52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-2004-832341","article-title":"Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME\/AON and hyperbaric oxygen therapy as a treatment modality","volume":"216","author":"Bernbeck","year":"2004","journal-title":"Klin Padiatr"},{"issue":"5","key":"2019111616231276000_B53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.5535\/arm.2016.40.5.871","article-title":"Effectiveness of lower energy density extracorporeal shock wave therapy in the early stage of avascular necrosis of the femoral head","volume":"40","author":"Han","year":"2016","journal-title":"Ann Rehabil Med"},{"key":"2019111616231276000_B54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2015.06.080","article-title":"Extracorporeal shockwave therapy for avascular necrosis of femoral head","author":"Wang","year":"2015"},{"issue":"4","key":"2019111616231276000_B55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/rheumatology\/ken020","article-title":"Extracorporeal shockwave therapy shows regeneration in hip necrosis","volume":"47","author":"Wang","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2019111616231276000_B56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/bem.21833","article-title":"Pulsed electromagnetic fields protect the balance between adipogenesis and osteogenesis on steroid-induced osteonecrosis of femoral head at the pre-collapse stage in rats","volume":"35","author":"Li","year":"2014","journal-title":"Bioelectromagnetics"},{"issue":"3","key":"2019111616231276000_B57","doi-asserted-by":"crossref","first-page":"e91581","DOI":"10.1371\/journal.pone.0091581","article-title":"A novel single pulsed electromagnetic field stimulates osteogenesis of bone marrow mesenchymal stem cells and bone repair","volume":"9","author":"Fu","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"2019111616231276000_B58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.5604\/15093492.1005091","article-title":"The effects of treatment the avascular necrosis of the femoral head with extracorporeal focused shockwave therapy","volume":"14","author":"Kusz","year":"2012","journal-title":"Ortop Traumatol Rehabil"},{"key":"2019111616231276000_B59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12891-015-0837-2","article-title":"Extracorporeal shock wave therapy in the treatment of primary bone marrow edema syndrome of the knee: a prospective randomised controlled study","volume":"16","author":"Gao","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"2019111616231276000_B60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5301\/HIP.2012.9748","article-title":"Efficacy of core decompression as treatment for osteonecrosis of the hip: a systematic review","volume":"22","author":"Rajagopal","year":"2012","journal-title":"Hip Int"},{"issue":"5","key":"2019111616231276000_B61","first-page":"420","article-title":"[The value of core decompression in treatment of femur head necrosis]","volume":"29","author":"Schneider","year":"2000","journal-title":"Orthopade"},{"issue":"5","key":"2019111616231276000_B62","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s11999-008-0184-9","article-title":"Do modern techniques improve core decompression outcomes for hip osteonecrosis?","volume":"466","author":"Marker","year":"2008","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"2019111616231276000_B63","first-page":"1117","article-title":"Nontraumatic osteonecrosis of the femoral head: ten years later","volume":"88","author":"Mont","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2019111616231276000_B64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s001320050460","article-title":"[Pathomorphological aspects and repair mechanisms of femur head necrosis]","volume":"29","author":"Plenk","year":"2000","journal-title":"Orthopade"},{"issue":"8 suppl 1","key":"2019111616231276000_B65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1054\/arth.2001.28722","article-title":"Outcomes of limited femoral resurfacing arthroplasty compared with total hip arthroplasty for osteonecrosis of the femoral head","volume":"16","author":"Mont","year":"2001","journal-title":"J Arthroplasty"},{"issue":"1","key":"2019111616231276000_B66","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1186\/s40064-016-3576-4","article-title":"Patient-reported outcomes of femoral osteotomy and total hip arthroplasty for osteonecrosis of the femoral head: a prospective case series study","volume":"5","author":"Kubo","year":"2016","journal-title":"Springerplus"},{"issue":"3","key":"2019111616231276000_B67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00452203","article-title":"The transtrochanteric anterior rotational osteotomy of Sugioka. Early and late results in idiopathic aseptic femoral head necrosis","volume":"106","author":"Eyb","year":"1987","journal-title":"Arch Orthop Trauma Surg"},{"issue":"5","key":"2019111616231276000_B68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00776-009-1363-6","article-title":"Evaluation of instability after transtrochanteric anterior rotational osteotomy for nontraumatic osteonecrosis of the femoral head","volume":"14","author":"Hiranuma","year":"2009","journal-title":"J Orthop Sci"},{"issue":"12","key":"2019111616231276000_B69","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1007\/s11999-010-1384-7","article-title":"The repair process of osteonecrosis after a transtrochanteric rotational osteotomy","volume":"468","author":"Yamamoto","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"2019111616231276000_B70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2009.09.001","article-title":"Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head","volume":"46","author":"Feng","year":"2010","journal-title":"Bone"},{"key":"2019111616231276000_B71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00003086-200212000-00003","article-title":"Treatment of osteonecrosis with autologous bone marrow grafting","volume":"405","author":"Hernigou","year":"2002","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"2019111616231276000_B72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-5413.45322","article-title":"Cell therapy of hip osteonecrosis with autologous bone marrow grafting","volume":"43","author":"Hernigou","year":"2009","journal-title":"Indian J Orthop"},{"issue":"3","key":"2019111616231276000_B73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00256-009-0800-0","article-title":"Treating osteonecrosis with autologous bone marrow cells","volume":"39","author":"Gangji","year":"2010","journal-title":"Skeletal Radiol"},{"issue":"6","key":"2019111616231276000_B74","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/00004623-200406000-00006","article-title":"Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study","volume":"86-A","author":"Gangji","year":"2004","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2019111616231276000_B75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bone.2011.07.032","article-title":"Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study","volume":"49","author":"Gangji","year":"2011","journal-title":"Bone"},{"issue":"1","key":"2019111616231276000_B76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bone.2011.11.002","article-title":"Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells","volume":"50","author":"Zhao","year":"2012","journal-title":"Bone"},{"issue":"1","key":"2019111616231276000_B77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4055\/cios.2016.8.1.1","article-title":"Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress","volume":"8","author":"Hernigou","year":"2016","journal-title":"Clin Orthop Surg"},{"key":"2019111616231276000_B78","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2014.04.034","article-title":"Osteonecrosis repair with bone marrow cell therapies: state of the clinical art","volume":"70","author":"Hernigou","year":"2015","journal-title":"Bone"},{"issue":"5","key":"2019111616231276000_B79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.arth.2011.08.008","article-title":"Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study","volume":"27","author":"Sen","year":"2012","journal-title":"J Arthroplasty"},{"issue":"8","key":"2019111616231276000_B80","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00264-012-1525-6","article-title":"The use of an injectable calcium sulphate\/calcium phosphate bioceramic in the treatment of osteonecrosis of the femoral head","volume":"36","author":"Civinini","year":"2012","journal-title":"Int Orthop"},{"issue":"1","key":"2019111616231276000_B81","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.4081\/or.2016.6162","article-title":"Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: a randomized prospective study","volume":"8","author":"Pepke","year":"2016","journal-title":"Orthop Rev (Pavia)"},{"issue":"11","key":"2019111616231276000_B82","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/leu.2008.217","article-title":"Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis","volume":"22","author":"M\u00fcller","year":"2008","journal-title":"Leukemia"},{"issue":"5","key":"2019111616231276000_B83","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2015-10-673848","article-title":"Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia","volume":"127","author":"Karol","year":"2016","journal-title":"Blood"},{"issue":"Suppl 1","key":"2019111616231276000_B84","first-page":"45","article-title":"Classification of avascular necrosis: a comparative study","volume":"65","author":"Steinberg","year":"1999","journal-title":"Acta Orthop Belg"},{"issue":"5","key":"2019111616231276000_B85","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1302\/0301-620X.83B5.0830672","article-title":"Volumetric analysis of osteonecrosis of the femur. Anatomical correlation using MRI","volume":"83","author":"Hernigou","year":"2001","journal-title":"J Bone Joint Surg Br"},{"key":"2019111616231276000_B86","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00003086-199408000-00023","article-title":"Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging","volume":"305","author":"Sugano","year":"1994","journal-title":"Clin Orthop Relat Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/14\/981\/877438\/advances007286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/14\/981\/877438\/advances007286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T17:01:23Z","timestamp":1659114083000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/14\/981\/16204\/Osteonecrosis-in-children-and-adolescents-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":86,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,6,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017007286","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]}}}